861 results on '"Holdenrieder, Stefan"'
Search Results
2. PATHFINDER-CHD: prospective registry on adults with congenital heart disease, abnormal ventricular function, and/or heart failure as a foundation for establishing rehabilitative, prehabilitative, preventive, and health-promoting measures: rationale, aims, design and methods
3. Incidence of systemic inflammatory response syndrome and patient outcome following transcatheter edge-to-edge mitral valve repair
4. German Society for Clinical Chemistry and Laboratory Medicine – areas of expertise: Division reports from the German Congress of Laboratory Medicine 2022 in Mannheim, 13–14 October 2022
5. Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group
6. Quantification of ventricular stress in univentricular hearts during early childhood using age-independent zlog-NT-proBNP
7. Systemic inflammatory response syndrome in patients undergoing transcatheter aortic valve implantation
8. Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers
9. A New Hierarchy of Research Evidence for Tumor Pathology: A Delphi Study to Define Levels of Evidence in Tumor Pathology
10. CA125: a novel cardiac biomarker for infants with congenital diaphragmatic hernia
11. Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
12. Profiling disease and tissue-specific epigenetic signatures in cell-free DNA
13. The rising tide of cell-free DNA profiling: from snapshot to temporal genome analysis
14. Pan-cancer screening by circulating tumor DNA (ctDNA) – recent breakthroughs and chronic pitfalls
15. The Percentage of [-2]Pro-Prostate-Specific Antigen and the Prostate Health Index Outperform Prostate-Specific Antigen and the Percentage of Free Prostate-Specific Antigen in the Detection of Clinically Significant Prostate Cancer and Can Be Used as Reflex Tests
16. Liquid profiling – circulating nucleic acid diagnostics gains momentum
17. A Novel Tool for the Rapid and Transparent Verification of Reference Intervals in Clinical Laboratories.
18. Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125.
19. Requirements for electronic laboratory reports according to the German guideline Rili-BAEK and ISO 15189
20. Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromes
21. Praktische Herausforderungen beim maschinellen Lernen: Auf die Datenaufbereitung kommt es an
22. Lung cancer tumor marker analysis: A clinical laboratory perspective
23. Lung cancer biomarkers: Raising the clinical value of the classical and the new ones
24. Targeted Sequencing of Human Satellite 2 Repeat Sequences in Plasma cfDNA Reveals Potential Breast Cancer Biomarkers
25. Influence of a 7‐day Transalpine Trail Run on cardiac biomarkers and myocardial function
26. Predicting Major Adverse Cardiovascular Events in Children With Age-Adjusted NT-proBNP
27. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy
28. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations
29. Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy
30. The prostate health index (PHI) density: Are there advantages over PHI or over the prostate-specific antigen density?
31. Assessment of SARS-CoV-2 rapid antigen tests
32. Satellite 2 repeat DNA in blood plasma as a candidate biomarker for the detection of cancer
33. Increased proBNP during extracorporeal life support (ECLS) is associated with poor outcome in neonates with congenital diaphragmatic hernia
34. Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis
35. Towards systematic nomenclature for cell-free DNA
36. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.
37. Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
38. SARS-CoV-2 antibody testing—questions to be asked
39. Clinically Meaningful Use of Blood Tumor Markers in Oncology
40. Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
41. C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework
42. Clinical Applicability of Tissue Polypeptide Antigen and CA-125 in Gynecological Malignancies
43. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update
44. Incidence of systemic inflammatory response syndrome and patient outcome following transcatheter edge-to-edge mitral valve repair
45. Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies
46. Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission
47. A pocket companion to cell-free DNA (cfDNA) preanalytics
48. CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan
49. Aggrecan: a new biomarker for acute type A aortic dissection
50. Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.